Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.45 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.45 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.45 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.45 |
| ▸ | P2RY14 | Q15391 | 5/20 | 0.44 |
| ▸ | P2RY6 | Q15077 | 7/20 | 0.43 |
| ▸ | P2RY2 | P41231 | 9/20 | 0.43 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17198648 | 1.00 | SLC28A1 (0.45) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL17198440 | 0.92 | TDP1 (0.43) | P2RY14P2RY6P2RY2P2RY4 | |
| SCHEMBL17198402 | 0.91 | DUT (0.39) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL18503515 | 0.90 | SLC28A1 (0.47) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL18503510 | 0.90 | SLC28A1 (0.47) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL17198588 | 0.90 | SLC28A1 (0.53) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL17198399 | 0.90 | SLC28A1 (0.53) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL18488843 | 0.90 | SLC28A1 (0.53) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL17198630 | 0.86 | SLC28A1 (0.45) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 | |
| SCHEMBL18512799 | 0.86 | SLC28A1 (0.45) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015161137-A1 | 3'-SUBSTITUTED METHYL OR ALKYNYL NUCLEOSIDES FOR THE TREATMENT OF HCV | IDENIX PHARMACEUTICALS, INC. (US) | 2015-10-22 | — | — | WO | disclosed |